Featured resources
Reduce the risk of future complications
In addition to screening for TB at the onset of immunotherapy, retesting every 1–2 years for patients who have a new or recurring risk factor should be considered. Risk factors include living in or extended travel to an endemic country, TB exposure, or employment in a healthcare or congregate setting. Risk factors such as smoking, substance use disorders, diabetes, etc. should also be considered.
Choose modern testing for your at-risk patients
Reduce the risk of TB with QuantiFERON-TB Gold Plus
References:
- NSTC/NTCA. Testing and treatment of latent tuberculosis infection in the United States: clinical recommendations. February 2021.